|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2022 | Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring | de Viron, Sylviane; Trotta, Laura; Schumacher, Helmut; Lomp, Hans-Juergen; Hoppner, Sebastiaan; Young, Steve; BUYSE, Marc | Journal Contribution | A1 |
| 2 | 2022 | Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology | Goldberg, Richard M.; Adams, Richard; BUYSE, Marc; Eng, Cathy; Grothey, Axel; Andre, Thierry; Sobrero, Alberto F.; Lichtman, Stuart M.; Benson, Al B.; Punt, Cornelis J. A.; Maughan, Tim; BURZYKOWSKI, Tomasz; Sommeijer, Dirkje; Saad, Everardo D.; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, Miriam; Schmoll, Hans-Joachim; Yoshino, Takayuki; Taieb, Julien; Tebbutt, Niall C.; Zalcberg, John; Tabernero, Josep; Van Cutsem , Eric; Matheson, Alastair; de Gramont, Aimery | Journal Contribution | A1 |
| 3 | 2022 | Surrogacy Beyond Prognosis: The Importance of “Trial-Level” Surrogacy | BUYSE, Marc; Saad, Everardo D.; BURZYKOWSKI, Tomasz; Regan, Meredith M.; Sweeney, Christopher S. | Journal Contribution | A1 |
| 4 | 2022 | On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes | De Backer, Mickael; LEGRAND, Catherine; Peron, Julien; Lambert, Alexandre; BUYSE, Marc | Journal Contribution | A1 |
| 5 | 2022 | Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator Outcomes | de Viron, Sylviane; Trotta, Laura; Steijn, William; Young, Steve; BUYSE, Marc | Journal Contribution | A1 |
| 6 | 2022 | The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustration | Jamoul, Corinne; Collette, Laurence; Coart, Elisabeth; D'Hollander, Koenraad; BURZYKOWSKI, Tomasz; Saad, Everardo D; BUYSE, Marc | Journal Contribution | A1 |
| 7 | 2022 | Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpoint | Barrado, Leandro Garcia; BURZYKOWSKI, Tomasz; LEGRAND, Catherine; BUYSE, Marc | Journal Contribution | A1 |
| 8 | 2021 | International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer | Fokas, Emmanouil; Appelt, Ane; Glynne-Jones, Robert; Beets, Geerard; Perez, Rodrigo; Garcia-Aguilar, Julio; Rullier, Eric; Joshua Smith, J.; Marijnen, Corrie; Peters, Femke P.; van der Valk, Maxine; Beets-Tan, Regina; Myint, Arthur S.; Gerard, Jean-Pierre; Bach, Simon P.; Ghadimi, Michael; Hofheinz, Ralf D.; Bujko, Krzysztof; Haustermans, Karin; Minsky, Bruce D.; Ludmir, Ethan; West, Nicholas P.; Gambacorta, Maria A.; Valentini, Vincenzo; BUYSE, Marc; Renehan, Andrew G.; Gilbert, Alexandra; Sebag-Montefiore, David; Roedel, Claus; Gani, Cihan | Journal Contribution | A1 |
| 9 | 2021 | Impact of follow-up on generalized pairwise comparisons for estimating the irinotecan benefit in advanced/metastatic gastric cancer | Chamseddine, AN; Oba, K; BUYSE, Marc; Boku, N; Bouche, O; Satar, T; Auperin, A; PAOLETTI, Xavier | Journal Contribution | A1 |
| 10 | 2021 | Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation study | Giai, Joris; Maucort-Boulch, Delphine; Ozenne, Brice; Chiem, Jean-Christophe; BUYSE, Marc; Peron, Julien | Journal Contribution | A1 |
| 11 | 2021 | A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons | Cantagallo, Eva; De Backer, Mickael; KICINSKI, Michal; Ozenne, Brice; Collette, Laurence; LEGRAND, Catherine; BUYSE, Marc; Peron, Julien | Journal Contribution | A1 |
| 12 | 2021 | Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial | Declercq , Jozefien; Van Damme, Karel F. A.; De Leeuw, Elisabeth; Maes, Bastiaan; Bosteels, Cedric; Tavernier, Simon J.; De Buyser, Stefanie; Colman, Roos; Hites, Maya; Verschelden, Gil; Fivez, Tom; Moerman , Filip; Demedts, Ingel K.; Dauby, Nicolas; De Schryver, Nicolas; Govaerts , Elke; Vandecasteele, Stefaan J.; Van Laethem, Johan; Anguille, Sebastien; VAN DER HILST, Jeroen; Misset, Benoit; Slabbynck, Hans; Wittebole, Xavier; Lienart, Fabienne; LEGRAND, Catherine; BUYSE, Marc; Stevens, Dieter; Bauters, Fre; Seys, Leen J. M.; Aegerter, Helena; Smole, Ursula; Bosteels, Victor; Hoste , Levi; Naesens, Leslie; Haerynck, Filomeen; Vandekerckhove, Linos; Depuydt, Pieter; van Braeckel, Eva; Rottey, Sylvie; Peene, Isabelle; Van Der Straeten, Catherine; Hulstaert, Frank; Lambrecht, Bart N. | Journal Contribution | A1 |
| 13 | 2021 | The Net Benefit of a treatment should take the correlation between benefits and harms into account | BUYSE, Marc; Saad, Everardo D.; Peron, Julien; Chiem, Jean-Christophe; De Backer, Mickael; Cantagallo, Eva; Ciani, Oriana | Journal Contribution | A1 |
| 14 | 2021 | The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research | Ranganathan, P; Chinnaswamy, G; Sengar, M; Gadgil, D; Thiagarajan, S; Bhargava, B; Booth, CM; BUYSE, Marc; Chopra, S; Frampton, C; Gopal, S; Grant, N; Krailo, M; Langley, R; Mathur, P; PAOLETTI, Xavier; Parmar, M; Purushotham, A; Pyle, D; Rajaraman, P; Stockler, MR; Sullivan, R; Swaminathan, S; Tannock, I; Trimble, E; Badwe, RA; Pramesh, CS | Journal Contribution | A1 |
| 15 | 2021 | Correcting the bias of the net benefit estimator due to right-censored observations | Peron, Julien; Idlhaj, Maryam; Maucort-Boulch, Delphine; Giai, Joris; Roy, Pascal; Collette, Laurence; BUYSE, Marc; Ozenne, Brice | Journal Contribution | A1 |
| 16 | 2021 | Evaluation of surrogate endpoints | MOLENBERGHS, Geert; SHKEDY, Ziv; BURZYKOWSKI, Tomasz; BUYSE, Marc; ALONSO ABAD, Ariel; VAN DER ELST, Wim | Book Section | B2 |
| 17 | 2020 | Unbiasedness and efficiency of non-parametric and UMVUE estimators of the probabilistic index and related statistics | VERBEECK, Johan; DELTUVAITE-THOMAS, Vaiva; BERCKMOES, Ben; BURZYKOWSKI, Tomasz; AERTS, Marc; THAS, Olivier; BUYSE, Marc; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 18 | 2020 | Progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in advanced/recurrent gastric cancer (AGC) treatment: Individual-patient-data (IPD) based meta-analysis of randomized trials | Oba, Koji; Paoletto, Xavier; Bang, Yung-Jue; Bouche, Olivier; Ducreux, Michel; Michiels, Stefan; Moehler, MarkusH; Morita, Satoshi; Ohashi, Yasuo; Sakamoto, Junichi; Sasako, Mitsuru; Shitara, Kohei; Van Cutsem, Eric; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | M |
| 19 | 2020 | Commentary on Bamat et al | Saad, Everardo D.; BUYSE, Marc | Journal Contribution | A2 |
| 20 | 2020 | Central statistical monitoring of investigator-led clinical trials in oncology | BUYSE, Marc; Trotta, Laura; Saad, Everardo D.; Sakamoto, Junichi | Journal Contribution | A1 |
Loading...
5
0
5
0
false